Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Reducing Human Error

June 1, 2012

Leading industry collaborators outline top 10 best practices for human error reduction.

Creating a Product Portfolio from the Ground Up

June 1, 2012

Mike Clayman, CEO of Flexion Therapeutics, talks about his company's strategy to focus on a single therapeutic area.

25 Years of Biopharmaceutical Innovation: An Expert Roundtable

June 1, 2012

Industry experts discuss significant achievements. Plus: What's in store for the future.

How to Respond to Consent Decrees

May 1, 2012

How to handle and respond to a consent decree.

A 25-Year Retrospective on the Biotech Business

May 1, 2012

This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."

FDA Explores Options to Expand Access to NonPrescription Drugs

May 1, 2012

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.

Changing Your Business Model

May 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.

Channeling Steve Jobs

May 1, 2012

Service providers must focus on delivering a superior customer experience.

A New Way to Think About Outsourcing Partnerships

May 1, 2012

Future sponsor-contract provider relationships will require more integration.

ADVERTISEMENT

ADVERTISEMENT

Click here